Clinical trials: Erectile Dysfunction Following Radical Prostatectomy
- Condition Erectile Dysfunction Following Radical Prostatectomy
- Funder type Industry (pharma, biotech, devices)
- Age group Children (under 18)
Erectile Dysfunction, Prostate Cancer
A Safety and Efficacy Study of Prograf in the Prevention of Erectile Dysfunction After Radical Prostatectomy
The purpose of the study is to compare the safety and effectiveness of Prograf in the prevention of erectile dysfunction in men after a radical prostatectomy.
- Trial name
- NCT00106392
- Testing
- Tacrolimus
- Where
- 6 sites in United States
- Volunteers
- 131 people
- Sponsor
- Astellas Pharma Inc